Tempus, Genmab Enter Oncology Biomarker Collaboration
Precision medicine company Tempus, and antibody therapeutics company Genmab have announced a strategic collaboration that will leverage Tempus’ sequencing capabilities and platform of integrated clinical...
PGDx Liquid Biopsy Test Shown to Predict Patient Response to Checkpoint Blockade Drugs
A study published by Clinical Cancer Research, a journal of the American Association for Cancer Research (AACR), demonstrates that Personal Genome Diagnostics’ (PGDx) liquid biopsy...
GeneCentric Therapeutics Acquires Select ImmunoGenomics for Biomarker Discovery
GeneCentric Therapeutics has broadened its tool set for subtyping cancer patients by acquiring Select ImmunoGenomics. The combined company now boasts a large, integrated set of RNA-based solutions for identifying the right patients for specific oncology drugs and improving response rates, treatment durability, and ultimately patient outcomes.
TB Treatment Tolerance Could be Addressed by Reversible Genetic Mutation
Scientists at the Rutgers New Jersey Medical School (NJMS) have found a genetically tractable cause of drug-tolerant tuberculosis (TB), which could pave the way...
Pathways of Pancreatic Cancer Drug Resistance Found
Scientists at Cold Spring Harbor Laboratory (CSHL) say they have found a way to tackle the problem of drug resistance and stop the growth...
8 Companion Diagnostic Developers Making a Mark
If companion diagnostics (CDx) were people, they would be old enough to drink. The first CDx won FDA approval in 1998, when Dako Denmark...
CHOP Researchers ID Schizophrenia Master Regulator Gene
Researchers at Children’s Hospital of Philadelphia (CHOP) have identified a gene that acts as a master regulator of schizophrenia during early human brain development,...
MIT, The Broad Release Data on 8,000 Human Microbial Strains
The human digestive tract is home to thousands of different strains of bacteria. Many of these are beneficial, while others contribute to health problems...
UnitedHealthcare To Cover Genetic Testing for Precision Medicine in Depression, Anxiety
The nation’s largest private health insurer, UnitedHealthcare, announced August 1 that it will cover testing that will allow physicians to match their patients to...
CRISPR-Chip Product, Genome Sensor, Launched as Cardea, Nanosens Merge
The CRISPR-Chip garnered much attention earlier this year when the novel graphene-based biosensor CRISPR-Cas technology was introduced in a Nature Biomedical Engineering publication in March....
